Showing results (471-480 of 758) with videos related to

Sort By:
Pageof 76
Journal of General Internal Medicine|January 13, 2026
Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid PopulationHillary Samples, Sharon Cook, Jialiang Hua, et al.
Plos Medicine|October 21, 2025
Impact of excessive social media use on adolescent depression and its consequences in France: An individual-based microsimulation modelNicolas Hoertel, Mark Olfson, Carlos Blanco, et al.
Medical Care|May 18, 2011
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US surveyBenjamin G Druss, Liping Zhao, Silke Von Esenwein, et al.
Translational Behavioral Medicine|March 13, 2026
Effects of a leadership-focused implementation strategy on uptake of digital measurement-based care in mental health clinics: a cluster randomized trialNathaniel J Williams, Gregory A Aarons, Mark G Ehrhart, et al.
Psychology in the Schools|April 11, 2017
Parent-Teacher Communication about Children with Autism Spectrum Disorder: An Examination of Collaborative Problem-SolvingGazi F Azad, Mina Kim, Steven C Marcus, et al.
Frontiers in Psychiatry|August 19, 2021
Developing a Tool to Measure Person-Centered Care in Service PlanningVictoria Stanhope, Daniel Baslock, Janis Tondora, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital DischargeJalpa A Doshi, Amy R Pettit, Jeffrey J Stoddard, et al.
Psychiatric Services (Washington, D.C.)|March 3, 2011
Bipolar medication use and adherence to antiretroviral therapy among patients with HIV-AIDS and bipolar disorderJames T Walkup, Ayse Akincigil, Sujoy Chakravarty, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 15, 2025
Association of Typical and Atypical Antipsychotics with Mortality in Older Adults with Schizophrenia: a 5-year multicenter prospective studyRaphaëlle Haddad, Marina Sánchez-Rico, Katayoun Rezaei, et al.
Addiction (Abingdon, England)|August 5, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patientsRachael K Ross, Edward V Nunes, Mark Olfson, et al.
Pageof 76